An oncolytic circular RNA therapy
Nat Cancer
.
2024 Jan;5(1):5-7.
doi: 10.1038/s43018-023-00627-7.
Authors
Alex G Hamilton
1
,
Michael J Mitchell
2
3
4
5
6
7
Affiliations
1
Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
2
Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
3
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
4
Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
5
Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
6
Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
7
Institute for RNA Innovation, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
PMID:
38177457
DOI:
10.1038/s43018-023-00627-7
No abstract available
MeSH terms
Oncolytic Virotherapy*
Oncolytic Viruses* / genetics
RNA, Circular
Substances
RNA, Circular